search
Back to results

Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes

Primary Purpose

IVM, PCOS (Polycystic Ovary Syndrome)

Status
Not yet recruiting
Phase
Not Applicable
Locations
Vietnam
Study Type
Interventional
Intervention
The way of Cumulus-oocyte complexes (COC) CAPA-IVM culture condition
Sponsored by
Mỹ Đức Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for IVM focused on measuring Low oxygen, CAPA-IVM, Cumulus-oocyte complexes

Eligibility Criteria

18 Years - 37 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: ≤38 years Having polycystic ovarian morphology: at least 25 follicles (2-9 mm) throughout the whole ovary and/or increased ovarian volume (>10ml) Having at least 20 follicles on the Oocyte Pick-up day Patients consent to culture embryos to the blastocyst Exclusion Criteria: Cases with severe male factor (concentration <5 million/ml, cryptozoospermia, azoospermia) Oocyte donation Pre-implantation genetic testing

Sites / Locations

  • My Duc Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Low Oxygen Concentration CAPA-IVM culture

Air Oxygen Concentration CAPA-IVM culture

Arm Description

Half of COCs were cultured in the CAPA step and IVM step in a low oxygen concentration (5%) and 6% carbon dioxide at 37 degree

Half of COCs were cultured in the CAPA step and IVM step in a air oxygen concentration (20%) and 6% carbon dioxide at 37 degree

Outcomes

Primary Outcome Measures

Number of blastocyst
Number of blastocyst obtained

Secondary Outcome Measures

Number of matured oocytes
Number of oocytes which have a polar body after maturation
Number of normal fertilized oocytes
Number of oocytes which have 2 pronuclear
Number of day-3 embryos
Number of day-3 embryos obtained
Number of good-quality day-3 embryos
Number of good quality Day 3 embryos obtained
Number of good-quality blastocyst
Number of good quality blastocyst obtained
Number of vitrified blastocyst
Number of vitrified blastocyst obtained
Positive pregnancy test
Serum human chorionic gonadotropin level greater than 25 mIU/mL
Clinical pregnancy
At least one gestational sac on ultrasound at 7 weeks' gestation with the detection of heart beat activity
Ongoing pregnancy
Defined as pregnancy with detectable heart rate at 12 weeks' gestation or beyond, after the completion of the first transfer
Implantation rate
Defined as the number of gestational sacs per number of embryos transferred
Multiple pregnancy
Defined as presence of more than one sac at early pregnancy ultrasound (6-8 weeks gestation)
Miscarriage
pregnancy loss at <12 weeks

Full Information

First Posted
October 12, 2023
Last Updated
October 18, 2023
Sponsor
Mỹ Đức Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT06087354
Brief Title
Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes
Official Title
Effect of Low Versus Air Oxygen Concentration in In-vitro Maturation With Biphasic Capacitation-IVM (CAPA-IVM) Culture of Human Cumulus-oocyte Complexes in PCOS Patients: a Sibling Oocyte Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 2023 (Anticipated)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mỹ Đức Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
IVM with a pre-maturation step, known as capacitation IVM (CAPA-IVM), has demonstrated enhanced maturation of human oocytes in vitro and successful live births. However, CAPA-IVM has shown lower rates of embryo formation when compared to conventional in vitro fertilization/ intra cytoplasmic sperm injection (IVF/ICSI) cycles. To optimize the CAPA-IVM culture system, this pilot study aims to evaluate the impact of low oxygen versus air oxygen concentrations on embryological outcomes in PCOS patients.
Detailed Description
Oocyte in vitro maturation (IVM) is an alternative approach to assisted reproductive technology (ART) that has the advantage of minimal stimulation, resulting in reduced hormone-related side effects and risks, especially in women with polycystic ovary syndrome (PCOS). Oocytes retrieved for IVM procedures are derived from a diverse pool of follicles with an average diameter of between 2 and 10mm and are characterized by variable cellular and molecular attributes that indicate their immature status. Therefore, the development of an IVM culture system that could enable and enhance the acquisition and synchronization of meiotic and developmental competence prior to the meiotic resumption is essential for optimizing human IVM protocols. IVM with a pre-maturation step, known as capacitation IVM (CAPA-IVM), has been shown to improve the competence of human oocytes matured in vitro and result in live births. The pre-maturation culture of CAPA-IVM utilizes C-type natriuretic peptide (CNP), and maturation takes place in the presence of amphiregulin (AREG), both of which are physiological compounds that have been shown to prevent spontaneous meiotic resumption of oocytes (CNP) and enhance oocyte competence (AREG) during IVM. To date, the results of pilot studies have shown that CAPA-IVM increases the rates of oocyte maturation, good-quality embryos on day 3 and good-quality blastocysts, resulting in a result, a higher embryo yield was obtained compared with standard IVM. Additionally, the reported cumulative live birth rate after use of CAPA-IVM, and its non-inferiority to the cumulative live birth rate with standard in vitro fertilization highlight the clinical utility and potential of this approach. Improvements in the culture system could make CAPA-IVM more effective, but these need to be investigated. The oxygen concentration during the IVM process plays a crucial role in oocyte maturation. The use of oxygen concentrations higher than physiological levels can lead to cell damage and affect embryo development. Recent studies in mice have suggested using lower oxygen concentrations to improve IVM outcomes. However, the effectiveness of using lower oxygen concentrations in human IVM remains unproven. Therefore, this pilot study aims to compare the effectiveness of lower oxygen concentration conditions versus air oxygen in CAPA-IVM on embryology outcomes in PCOS women.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
IVM, PCOS (Polycystic Ovary Syndrome)
Keywords
Low oxygen, CAPA-IVM, Cumulus-oocyte complexes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low Oxygen Concentration CAPA-IVM culture
Arm Type
Experimental
Arm Description
Half of COCs were cultured in the CAPA step and IVM step in a low oxygen concentration (5%) and 6% carbon dioxide at 37 degree
Arm Title
Air Oxygen Concentration CAPA-IVM culture
Arm Type
Experimental
Arm Description
Half of COCs were cultured in the CAPA step and IVM step in a air oxygen concentration (20%) and 6% carbon dioxide at 37 degree
Intervention Type
Other
Intervention Name(s)
The way of Cumulus-oocyte complexes (COC) CAPA-IVM culture condition
Intervention Description
Cumulus-oocyte complexes (COC) will be cultured in CAPA-IVM 24 hrs capacitation followed by 30h maturation. The first group will be cultured in low oxygen concentration (5%Oxygen), 6% carbon dioxide at 37 degree. The second group will be cultured in air oxygen concentration (20%Oxygen), 6% carbon dioxide at 37 degree.
Primary Outcome Measure Information:
Title
Number of blastocyst
Description
Number of blastocyst obtained
Time Frame
At least 5 days after intra-cytoplasmic sperm injection
Secondary Outcome Measure Information:
Title
Number of matured oocytes
Description
Number of oocytes which have a polar body after maturation
Time Frame
Two days after oocytes pick-up
Title
Number of normal fertilized oocytes
Description
Number of oocytes which have 2 pronuclear
Time Frame
16-18 hours after intra-cytoplasmic sperm injection
Title
Number of day-3 embryos
Description
Number of day-3 embryos obtained
Time Frame
At least 3 days after intra-cytoplasmic sperm injection
Title
Number of good-quality day-3 embryos
Description
Number of good quality Day 3 embryos obtained
Time Frame
At least 3 days after intra-cytoplasmic sperm injection
Title
Number of good-quality blastocyst
Description
Number of good quality blastocyst obtained
Time Frame
At least 5 days after intra-cytoplasmic sperm injection
Title
Number of vitrified blastocyst
Description
Number of vitrified blastocyst obtained
Time Frame
At least 5 days after intra-cytoplasmic sperm injection
Title
Positive pregnancy test
Description
Serum human chorionic gonadotropin level greater than 25 mIU/mL
Time Frame
At 2 weeks after the completion of the first frozen embryo transfer
Title
Clinical pregnancy
Description
At least one gestational sac on ultrasound at 7 weeks' gestation with the detection of heart beat activity
Time Frame
5 weeks after embryo placement after the completion of the first transfer
Title
Ongoing pregnancy
Description
Defined as pregnancy with detectable heart rate at 12 weeks' gestation or beyond, after the completion of the first transfer
Time Frame
At 12 weeks' gestation
Title
Implantation rate
Description
Defined as the number of gestational sacs per number of embryos transferred
Time Frame
3 weeks after embryo transferred after the completion of the first transfer
Title
Multiple pregnancy
Description
Defined as presence of more than one sac at early pregnancy ultrasound (6-8 weeks gestation)
Time Frame
5 weeks after embryo placement after the completion of the first transfer
Title
Miscarriage
Description
pregnancy loss at <12 weeks
Time Frame
at 12 weeks of gestation after the completion of the first transfer

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
37 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≤38 years Having polycystic ovarian morphology: at least 25 follicles (2-9 mm) throughout the whole ovary and/or increased ovarian volume (>10ml) Having at least 20 follicles on the Oocyte Pick-up day Patients consent to culture embryos to the blastocyst Exclusion Criteria: Cases with severe male factor (concentration <5 million/ml, cryptozoospermia, azoospermia) Oocyte donation Pre-implantation genetic testing
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Huy H Pham
Phone
+84 966145510
Email
huy.ph@myduchospital.vn
First Name & Middle Initial & Last Name or Official Title & Degree
Anh TL Vu
Phone
+84 389565849
Email
anh.vtl@myduchospital.vn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tuong M Ho
Organizational Affiliation
Mỹ Đức Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
My Duc Hospital
City
Ho Chi Minh City
ZIP/Postal Code
70000
Country
Vietnam

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31399916
Citation
Sanchez F, Le AH, Ho VNA, Romero S, Van Ranst H, De Vos M, Gilchrist RB, Ho TM, Vuong LN, Smitz J. Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles. J Assist Reprod Genet. 2019 Oct;36(10):2135-2144. doi: 10.1007/s10815-019-01551-5. Epub 2019 Aug 9.
Results Reference
background
PubMed Identifier
32974672
Citation
Vuong LN, Ho VNA, Ho TM, Dang VQ, Phung TH, Giang NH, Le AH, Pham TD, Wang R, Smitz J, Gilchrist RB, Norman RJ, Mol BW. In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial. Hum Reprod. 2020 Nov 1;35(11):2537-2547. doi: 10.1093/humrep/deaa240.
Results Reference
background
PubMed Identifier
31902102
Citation
Vuong LN, Le AH, Ho VNA, Pham TD, Sanchez F, Romero S, De Vos M, Ho TM, Gilchrist RB, Smitz J. Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome. J Assist Reprod Genet. 2020 Feb;37(2):347-357. doi: 10.1007/s10815-019-01677-6. Epub 2020 Jan 4.
Results Reference
background
PubMed Identifier
17192892
Citation
Preis KA, Seidel GE Jr, Gardner DK. Reduced oxygen concentration improves the developmental competence of mouse oocytes following in vitro maturation. Mol Reprod Dev. 2007 Jul;74(7):893-903. doi: 10.1002/mrd.20655.
Results Reference
background
PubMed Identifier
37531262
Citation
Akin N, Ates G, Mengden L, Herta AC, Meriggioli C, Billooye K, Stocker WA, Ghesquiere B, Harrison CA, Cools W, Klamt F, Massie A, Smitz J, Anckaert E. Effects of lactate, super-GDF9 and low oxygen tension during biphasic in vitro maturation on the bioenergetic profiles of mouse cumulus-oocyte-complex. Biol Reprod. 2023 Aug 2:ioad085. doi: 10.1093/biolre/ioad085. Online ahead of print.
Results Reference
background

Learn more about this trial

Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes

We'll reach out to this number within 24 hrs